LOS ALTOS, Calif.–(BUSINESS WIRE)–Fist Assist Devices, LLC, a novel medical device start-up based in Silicon Valley, Calif., today announced the formation of its first global medical advisory board (MAB). Fist Assist Devices, LLC has developed the only wearable patent-protected intermittent compression device for vein dilation for patients with end-stage renal […]
Other News
Late-Breaking Data Presentations at ACC 2019 Highlight Abbott’s Leading Cardiovascular Portfolio
ABBOTT PARK, Ill., March 6, 2019 /PRNewswire/ — Key medical devices across Abbott’s (NYSE: ABT) cardiovascular portfolio will be highlighted in five late-breaking clinical trials at the American College of Cardiology’s 68th Annual Scientific Session (ACC 2019) from March 16 – 18 in New Orleans. The late-breaking studies showcase the depth and breadth of the company’s cardiovascular portfolio, providing new data […]
REVA Announces Extension to Voluntary Suspension of Trading
SAN DIEGO, March 05, 2019 (GLOBE NEWSWIRE) — REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”) said today that on 6 March 2019 (AEDT), the Australian Securities Exchange issued a market announcement indicating that the securities of the Company will remain suspended from quotation at the Company’s request until […]
BioSig Appoints Barry Keenan as Vice President of Engineering
Santa Monica, CA, March 06, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, today announced that the Company appointed Dr. Barry Keenan, Ph.D, MBA, PMP to head up BioSig’s […]
Bardy Diagnostics™ Selected As Finalist In The Impact Pediatric Health Competition At SXSW 2019 And Advances In The MedTech Innovator Competition
SEATTLE, March 6, 2019 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, including the Carnation Ambulatory Monitor (“CAM™”), the industry’s first P-wave centric™ ambulatory cardiac patch monitor and arrhythmia detection device, announced it has been selected as a finalist in the fifth annual Impact Pediatric Health Competition to […]
Le Bonheur Children’s Hospital to expand Heart Institute
MEMPHIS, Tenn., March 5, 2019 /PRNewswire/ — Le Bonheur Children’s Hospital will expand its Heart Institute with a two-story, $37.6 million addition. This expansion will add 19 additional beds to the Heart Institute to create a 31-bed dedicated Cardiovascular Unit. The hospital will expand west to the corner of Poplar Avenue and Dunlap Street. “We […]
CryoLife to Present at Cowen and Company 39th Annual Health Care Conference
ATLANTA, March 5, 2019 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming Cowen and Company 39th Annual Health Care Conference on Monday, March 11, 2019 at The Boston Marriott Copley Place in Boston. A live webcast of the Company’s presentation is […]
Water Street’s Partnership with Leading Medical Products Company Leads to FDA Approval and Launch of Ready-to-Use Cardiovascular Medicine Eptifibatide
CHICAGO, March 6, 2019 /PRNewswire/ — Water Street Healthcare Partners, a strategic investor focused exclusively on the health care industry, announced today that its development partnership with a leading medical products company has resulted in the U.S. Food and Drug Administration (FDA) approval and launch of the ready-to-use cardiovascular medication, eptifibatide. It is […]
Endologix Announces Approval of Reverse Stock Split
IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (the “Company”) (NASDAQ: ELGX) previously announced that a proposal was approved at its Special Meeting of Stockholders, held February 22, 2019, authorizing its Board of Directors to amend the Company’s certificate of incorporation to effect a reverse stock split of the Company’s issued and outstanding shares […]
FDA Grants Saranas De Novo Designation for the Early BirdTM Bleed Monitoring System
HOUSTON–(BUSINESS WIRE)–Saranas Inc., a medical device company with innovative technology for real-time detection and monitoring of internal bleeding during endovascular procedures, today announced that it has been granted de novo classification by the U.S. Food and Drug Administration (FDA) for the Early Bird Bleed Monitoring System. According to a recent […]



